Trump’s new tariff plan on generic drugs in America: 2 years 0%, then 100% and 200% duty; Possible impact on Indian pharmaceutical companies

Trump’s new tariff plan on generic drugs in America: 2 years 0%, then 100% and 200% duty; Possible impact on Indian pharmaceutical companies

US President Donald Trump has announced to impose tariffs on generic medicines imported into America. For the next two years, these medicines will be able to go to America without any duty, but after that the tariff will be 100% and then 200%. What impact will Trump’s decision have on the Indian pharma industry and…

Read More
Zydus Lifesciences Taps 3 Bankers For Rs 5,000-Crore QIP; Issue Likely In Early 2026

Zydus Lifesciences Taps 3 Bankers For Rs 5,000-Crore QIP; Issue Likely In Early 2026

Last Updated:November 20, 2025, 12:44 IST Zydus Lifesciences has appointed three investment banks as advisers as it prepares to raise up to Rs 5,000 crore through QIP Zydus QIP Zydus Lifesciences (formerly Cadila Lifesciences) has appointed three investment banks as advisers as it prepares to raise up to Rs 5,000 crore through a qualified institutional…

Read More